MRC Epidemiology Unit

 

Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND Study.

Abbasi A, Kieneker LM, Corpeleijn E, Gansevoort RT, Gans RO, Struck J, de Boer RA, Hillege HL, Stolk RP, Navis G, Bakker SJ

Clinical chemistry. May 2016

(DOI : 10.1373/clinchem.2016.259275)

---

Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.

Abbasi A, Corpeleijn E, Gansevoort RT, Gans RO, Struck J, Schulte J, Hillege HL, van der Harst P, Stolk RP, Navis G, Bakker SJ

Diabetologia. Feb 2014

(DOI : 10.1007/s00125-014-3278-9)

---